These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9916622

  • 1. High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
    Siegert W, Rick O, Beyer J.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S7-9. PubMed ID: 9916622
    [No Abstract] [Full Text] [Related]

  • 2. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W.
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 4. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A, Biron P, Philip I, Blay JY, Droz JP.
    Bull Cancer; 1999 Apr 15; 86(4):391-9. PubMed ID: 10341344
    [Abstract] [Full Text] [Related]

  • 5. High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.
    Siegert W, Beyer J.
    Bone Marrow Transplant; 1996 Sep 15; 18 Suppl 1():S60. PubMed ID: 8899176
    [No Abstract] [Full Text] [Related]

  • 6. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I, Miyake H, Yamada Y, Yamanaka K, Furukawa J, Kumano M, Takenaka A, Fujisawa M.
    Anticancer Drugs; 2006 Oct 15; 17(9):1057-66. PubMed ID: 17001179
    [Abstract] [Full Text] [Related]

  • 7. Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
    Mardiak J, Fuchsberger P, Lakota J, Sálek T, Sycová-Milá Z, Drahokoupilová M, Baláz M, Koza I.
    Neoplasma; 2000 Oct 15; 47(4):239-43. PubMed ID: 11043829
    [Abstract] [Full Text] [Related]

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 9. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A, Ueoka H, Kiura K, Tabata M, Sunami K, Katayama Y, Yamane H, Hiraki A, Harada M.
    Anticancer Res; 1999 May 15; 19(1B):693-8. PubMed ID: 10216478
    [Abstract] [Full Text] [Related]

  • 10. Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
    Cronin S, Uberti JP, Ayash LJ, Raith C, Ratanatharathorn V.
    Bone Marrow Transplant; 2000 Dec 15; 26(11):1247-9. PubMed ID: 11149742
    [Abstract] [Full Text] [Related]

  • 11. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
    Nakagawa S, Miki T, Akaza H, Ozono S, Okano T, Sonoda Y, Tsukamoto T, Terachi T, Naito K, Naito S, Nishiyama T, Nonomura N, Hara I, Hoshi S, Yoshida O.
    Hinyokika Kiyo; 1999 Nov 15; 45(11):805-9. PubMed ID: 10637748
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
    Lotz JP, André T, Bouleuc C, Péne F, Gattegno B, Bazelly B, Houry S, Chapiro J, Selle F, Gligorov J, Izrael V.
    Bone Marrow Transplant; 1996 Sep 15; 18 Suppl 1():S55-9. PubMed ID: 8899175
    [No Abstract] [Full Text] [Related]

  • 14. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR.
    Semin Oncol; 1996 Jun 15; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [Abstract] [Full Text] [Related]

  • 15. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
    Cancer Invest; 2008 May 15; 26(4):401-6. PubMed ID: 18443961
    [Abstract] [Full Text] [Related]

  • 16. Early utilization of high-dose chemotherapy in germ cell tumors.
    Nichols CR.
    Bone Marrow Transplant; 1996 Sep 15; 18 Suppl 1():S50-2. PubMed ID: 8899173
    [No Abstract] [Full Text] [Related]

  • 17. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D.
    J Clin Oncol; 1994 Jun 15; 12(6):1223-31. PubMed ID: 7911158
    [Abstract] [Full Text] [Related]

  • 18. Poor-risk testicular cancer and high-dose chemotherapy.
    Motzer RJ, Sheinfeld S.
    J Clin Oncol; 2003 Nov 15; 21(22):4073-4. PubMed ID: 14568986
    [No Abstract] [Full Text] [Related]

  • 19. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H, Wolfe L, Kretschmar C.
    Pediatr Blood Cancer; 2009 Jul 15; 53(1):33-6. PubMed ID: 19326417
    [Abstract] [Full Text] [Related]

  • 20. [Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
    Fléchon A, Droz JP.
    Bull Cancer; 2001 Sep 15; 88(9):852-7. PubMed ID: 11604357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.